Jerjes Waseem, Upile Tahwinder, Hamdoon Zaid, Mosse Charles Alexannder, Akram Sarah, Hopper Colin
University College London Hospitals Head, Neck Centre, London, UK.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180-7. doi: 10.1016/j.tripleo.2010.09.078. Epub 2011 Jan 12.
Oral cancer is the sixth most common cancer in the world. The incidence of oral squamous cell carcinoma (OSCC) continues to be high, if not increasing. This prospective study assessed the oncological outcomes following transoral CO(2) laser resection of T1/T2 N0 OSCC. Patients' 3-year disease-specific survival and disease-free survival were evaluated.
The patients' data included a range of clinical, operative, and histopathological variables related to the status of the surgical margins. Data collection also included recurrence, cause of death, date of death, and last clinic review. Ninety patients (64 males and 26 females) participated in this study. Their mean age at the first diagnosis of OSCC was 63.5 years. Two thirds of the patients were Caucasians. Usually patients present with an ulcer of the tongue, floor of mouth, or buccal mucosa. Current and ex-smokers represented 82.2% of the cohort, whereas current and ex-drinkers were 78.9%. Comorbidities included history of oral lichen planus, oral submucous fibrosis, immunodeficiency, oral dysplasia, or OSCC. Clinically, 81 patients had T1N0 disease and 9 had T2N0 disease.
Pathologic analysis revealed that nearly half of the patients had moderately differentiated OSCC, 18 moderately to poorly differentiated, and 19 poorly differentiated carcinoma. Study of the tumor margins was carried out and showed a mean of 5.7-mm depth of invasion; tumor clearance was primarily achieved in 73 patients. Recurrence was identified in 11 (12%) patients. The mean age of first diagnosis of the recurrence group was 76.4 years. The most common clinical presentation in the recurrence group was an ulcer involving the tongue or buccal mucosa; most commonly were identified in current or ex-smokers or drinkers. Recurrence was associated with clinical N-stage disease. The surgical margins in this group were also evaluated following relaser excision or surgical excision ± neck dissection. Follow-up resulted in a 3-year survival of 86.7%. Twelve patients died: 9 from noncancer-related causes, 2 from locoregional disease spread, and 1 from distant metastasis to the lungs.
Squamous cell carcinoma of the oral cavity has a poor overall prognosis with a high tendency to recur at the primary site and extend to involve the locoregional lymph nodes. The overall results of this study suggest that CO(2) laser is a comparable modality to other traditional interventions (surgery) in the management of low-risk (T1/T2) tumors of the oral cavity.
口腔癌是全球第六大常见癌症。口腔鳞状细胞癌(OSCC)的发病率即便没有上升,也持续居高不下。本前瞻性研究评估了经口二氧化碳激光切除T1/T2 N0期OSCC后的肿瘤学结局。对患者的3年疾病特异性生存率和无病生存率进行了评估。
患者数据包括一系列与手术切缘状态相关的临床、手术和组织病理学变量。数据收集还包括复发情况、死亡原因、死亡日期和最后一次临床复查。90例患者(64例男性和26例女性)参与了本研究。他们首次诊断为OSCC时的平均年龄为63.5岁。三分之二的患者为白种人。患者通常表现为舌、口底或颊黏膜溃疡。目前吸烟者和既往吸烟者占该队列的82.2%,目前饮酒者和既往饮酒者占78.9%。合并症包括口腔扁平苔藓病史、口腔黏膜下纤维化、免疫缺陷、口腔发育异常或OSCC。临床上,81例患者为T1N0期疾病,9例为T2N0期疾病。
病理分析显示,近一半患者患有中度分化的OSCC,18例为中度至低度分化,19例为低度分化癌。对肿瘤切缘进行了研究,显示平均浸润深度为5.7毫米;73例患者主要实现了肿瘤清除。11例(12%)患者出现复发。复发组首次诊断的平均年龄为76.4岁。复发组最常见的临床表现是累及舌或颊黏膜的溃疡;最常见于目前吸烟者、既往吸烟者或饮酒者。复发与临床N分期疾病相关。对该组患者在再次激光切除或手术切除±颈部清扫后也评估了手术切缘。随访结果显示3年生存率为86.7%。12例患者死亡:9例死于非癌症相关原因,2例死于局部疾病扩散,1例死于肺远处转移。
口腔鳞状细胞癌总体预后较差,原发部位复发倾向高,并易累及局部淋巴结。本研究的总体结果表明,在治疗口腔低风险(T1/T2)肿瘤方面,二氧化碳激光是一种与其他传统干预措施(手术)相当的治疗方式。